For example, Ac‐ANXA1 (2‐26) encapsulated within targeted polymeric nanoparticles (annexin 1‐(2‐26) collagen IV nanoparticles) accelerated healing of murine colonic wounds and colitis, suggesting that development of nanoparticles containing pro‐resolving mediators may be a viable strategy for local deliveries to an injured site (Leoni et al., 2015). The gene discussed is ANXA1; the disease is colitis.